Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.

Incidence rates and risk factors for type 2 diabetes in low-risk populations are not well documented. We investigated these in white individuals who were aged 40-79 years and from the population of Bruneck, Italy. Of an age- and sex-stratified random sample of 1,000 individuals who were identified in 1990, 919 underwent an oral glucose tolerance test (OGTT) and an assessment of physiological risk factors for diabetes, including insulin resistance (homeostasis model assessment, HOMA-IR), and postchallenge insulin response (Sluiter's Index). Diabetes at baseline by fasting or 2-h OGTT plasma glucose (World Health Organization criteria, n = 82) was excluded, leaving 837 individuals who were followed for 10 years. Incident cases of diabetes were ascertained by confirmed diabetes treatment or a fasting glucose >or=7.0 mmol/l. At follow-up, 64 individuals had developed diabetes, corresponding to a population-standardized incidence rate of 7.6 per 1,000 person-years. Sex- and age-adjusted incidence rates were elevated 11-fold in individuals with impaired fasting glucose at baseline, 4-fold in those with impaired glucose tolerance, 3-fold in overweight individuals, 10-fold in obese individuals, and approximately 2-fold in individuals with dyslipidemia or hypertension. Incidence rates increased with increasing HOMA-IR and decreasing Sluiter's Index. As compared with normal insulin sensitivity and normal insulin response, individuals with low insulin sensitivity and low insulin response had a sevenfold higher risk of diabetes. Baseline impaired fasting glucose, BMI, HOMA-IR, and Sluiter's Index were the only independent predictors of incident diabetes in multivariate analyses. We conclude that approximately 1% of European white individuals aged 40-79 years develop type 2 diabetes annually and that "subdiabetic" hyperglycemia, obesity, insulin resistance, and impaired insulin response to glucose are independent predictors of diabetes.

[1]  W. Reitsma,et al.  Glucose Tolerance and Insulin Release, A Mathematical Approach: I. Assay of the Beta-cell Response After Oral Glucose Loading , 1976, Diabetes.

[2]  G. Sartor,et al.  Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation , 1980, Diabetes.

[3]  Daniel L. McGee,et al.  Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. , 1981, American journal of epidemiology.

[4]  P. Savage,et al.  Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. , 1981, American journal of epidemiology.

[5]  D. E. Lamphiear,et al.  Diabetes mellitus in Tecumseh, Michigan. Prevalence, incidence, and associated conditions. , 1982, American journal of epidemiology.

[6]  L. Melton,et al.  Incidence of Diabetes Mellitus by Clinical Type , 1983, Diabetes Care.

[7]  UK Prospective Diabetes Study. V. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet 4-cell function. Multi-centre study. , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[8]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[9]  Multicenter Study.  UK Prospective Diabetes Study V. Characteristics of Newly presenting Type 2 Diabetic Patients: Estimated Insulin Sensitivity and Islet B‐cell Function , 1988 .

[10]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[11]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[12]  E. Barrett-Connor,et al.  Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. , 1990, American journal of epidemiology.

[13]  S. Haffner,et al.  Increased Incidence of Type II Diabetes Mellitus in Mexican Americans , 1991, Diabetes Care.

[14]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[15]  C. Cobelli,et al.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. , 1993, The Journal of clinical investigation.

[16]  Daniel L. McGee,et al.  Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study. , 1993, American journal of epidemiology.

[17]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[18]  S. Kiechl,et al.  Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  P. Whincup,et al.  Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men , 1995, BMJ.

[20]  S. Haffner,et al.  The Homeostasis Model in the San Antonio Heart Study , 1997, Diabetes Care.

[21]  S. Kiechl,et al.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.

[22]  L. Melton,et al.  Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes , 1998, Diabetes Care.

[23]  E. Arnesen,et al.  Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study. , 1998, American Journal of Epidemiology.

[24]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[25]  S. Haffner,et al.  Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.

[26]  B. Howard,et al.  Re: "Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark study". , 1999, American journal of epidemiology.

[27]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[28]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[29]  A. Folsom,et al.  Incident Type 2 Diabetes Mellitus in African American and White Adults , 2000 .

[30]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[31]  C. Bogardus,et al.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. , 2000, American journal of epidemiology.

[32]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[33]  P. Wilson,et al.  Parental transmission of type 2 diabetes: the Framingham Offspring Study. , 2000, Diabetes.

[34]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[35]  L. Groop,et al.  Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. , 2000, Diabetes.

[36]  R. Unger,et al.  Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. , 2001, Diabetes.

[37]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[38]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[39]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[40]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[41]  D. Schwartz,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[42]  T. Gill,et al.  Obesity: epidemiology and possible prevention. , 2002, Best practice & research. Clinical endocrinology & metabolism.

[43]  Vittorio Cacciatori,et al.  HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. , 2002, Diabetes care.

[44]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[45]  C. Meisinger,et al.  Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. , 2002, Archives of internal medicine.

[46]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[47]  D. Schwartz,et al.  Toll-like receptor 4 polymorphisms and atherogenesis in humans. , 2002 .

[48]  J. Meigs,et al.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. , 2003, Diabetes.

[49]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[50]  M. Stumvoll,et al.  Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. , 2003, Diabetes.

[51]  S. Kiechl,et al.  Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. , 2003, Diabetes care.

[52]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[53]  Paul Knekt,et al.  Whole-grain and fiber intake and the incidence of type 2 diabetes. , 2003, The American journal of clinical nutrition.

[54]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[55]  H. King,et al.  The natural history of impaired glucose tolerance in the Micronesian population of Nauru: A six-year follow-up study , 2004, Diabetologia.

[56]  K. Eriksson,et al.  Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men , 1996, Diabetologia.

[57]  A. Boulton,et al.  Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients , 1996, Diabetologia.

[58]  E. Bonora,et al.  The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality , 1995, Diabetologia.